MYC and neoplasm: As (i) MYC tumors express lower levels of active DNA demethylases as well as other genes being involved in DNA demethylation, and (ii) DNMTs are upregulated in RT56,57, we hypothesize that their inhibition impacts tumor outcome through counterbalancing the epigenetic status of these tumors.